Kualitas bukti 4.0/5
Skor tinjauan delapan dimensi terhadap rubrik kualitas . Setiap dimensi dinilai 1–5.
- D1 Dasar sumber
- 4/5
- D2 Otoritas sumber
- 5/5
- D3 Aritmetika
- 4/5
- D4 Ketidakpastian
- 4/5
- D5 Cakupan
- 4/5
- D6 Prosa
- 4/5
- D7 Kejujuran persepsi
- 3/5
- D8 Kelengkapan peringatan
- 4/5
≈ Sama mungkinnya dengan
Dipersepsikan
Selama 2019–2020, liputan media AS tentang wabah EVALI — puluhan remaja dirawat di rumah sakit dengan cedera paru misterius setelah vape — menimbulkan ketakutan orang tua yang intens tentang bahaya pernapasan terkait vape. Gambar remaja yang sebelumnya sehat dengan ventilator sangat jelas dan spesifik. Ketakutan itu bertahan pada periode pascawabah meskipun wabah tersebut ditelusuri ke bahan pencemar spesifik (vitamin E asetat dalam kartrid THC ilegal) yang sebagian besar telah dihapus dari pasokan setelah penyelidikan CDC. Ketakutan saat ini tentang vape mungkin mencampuradukkan risiko EVALI era wabah dengan vape nikotin atau vape tanpa nikotin yang berkelanjutan.
Sumber: intuisi redaksi, bukan hasil survei
Aktual
~2.807 rawat inap di AS selama jendela wabah 2019–2020; tingkat wabah ~1 dari 1.070 remaja/dewasa muda AS yang vape
Remaja dan dewasa muda AS yang vape selama wabah EVALI 2019–2020 (jumlah kasus EVALI CDC atas penyebut estimasi kerja internal ~3 juta; anchor NYTS 2019 yang dikutip menempatkan pengguna rokok elektrik muda saat ini pada ~5,3 juta)
Tampilkan perhitungan
Surveilans EVALI CDC: 2.807 kasus rawat inap dan 68 kematian per Februari 2020 (ketika CDC menghentikan surveilans aktif setelah agen penyebab utama — vitamin E asetat dalam kartrid THC — diidentifikasi dan sebagian besar dihapus dari pasokan). ~82 % kasus melibatkan produk mengandung THC; 57 % melibatkan THC sekaligus nikotin. Penyebut: estimasi kerja internal ~3.000.000 untuk remaja + dewasa muda yang vape selama jendela puncak (BUKAN total survei terbit yang dikutip langsung). Sebagai skala, anchor NYTS 2019 yang dikutip (Cullen et al., JAMA) menempatkan pengguna rokok elektrik muda saat ini pada ~5,3 juta (4,1 juta SMA + 1,2 juta SMP), dan seri kasus EVALI memiliki usia median 21 — jadi populasi terpapar sebenarnya (menambah dewasa muda usia kuliah) kemungkinan ≥5 juta. Menggunakan penyebut internal 3 juta: 2.807 / 3.000.000 ≈ 0,00094 (kira-kira 1 dari 1.070). Karena angka populasi yang dapat dikutip (≥5,3 juta) LEBIH BESAR dari 3 juta, tingkat wabah sebenarnya LEBIH JARANG daripada yang ditampilkan 1 dari 1.070 (mis. 2.807 / 5.300.000 ≈ 1 dari 1.888) — headline karenanya berada di sisi yang lebih mengkhawatirkan dari bukti yang dapat dikutip, bukan konservatif. Secara arah, tingkat untuk pengguna produk THC secara khusus lebih tinggi daripada tingkat semua-vaper (~82 % kasus; mereka yang hanya menggunakan produk berbasis nikotin memiliki paparan EVALI mendekati nol), sehingga membatasi penyebut ke pengguna THC menaikkan tingkat sementara membatasi pembilang tidak. Tingkat latar EVALI pasca-penghapusan-vit-E lebih rendah satu orde besaran. Rendah (0,0001): tingkat latar saat ini (pascawabah) untuk produk nikotin yang diregulasi. Tinggi (0,005): tingkat puncak wabah bagi mereka yang menggunakan kartrid THC ilegal secara khusus.
Catatan: EVALI adalah wabah yang disebabkan oleh bahan pencemar spesifik — vitamin E aset…
EVALI adalah wabah yang disebabkan oleh bahan pencemar spesifik — vitamin E asetat — yang ditambahkan ke kartrid vape THC ilegal di pasar gelap AS. Ini adalah fenomena khas AS tanpa wabah internasional yang sebanding; negara lain tidak melihat klaster EVALI setara karena pasar produk ganja mereka berbeda. Tingkat era wabah (2019–2020) tidak berlaku untuk periode pasca-penghapusan-vitamin-E, dan peringatan ini berlaku khusus untuk kartrid vape THC ilegal/tidak diregulasi, bukan untuk rokok elektrik nikotin yang diregulasi. Vape nikotin remaja saat ini (7,8 % siswa SMA AS pada 2024) membawa profil risiko spesifik EVALI yang berbeda dan lebih rendah. Efek pernapasan dan kardiovaskular jangka panjang dari vape nikotin kronis pada remaja adalah pertanyaan penelitian tersendiri dan berkelanjutan yang tidak tercakup oleh entri ini, yang dilingkupi pada hasil akut EVALI spesifik.
Risiko terkait
Risiko lain dengan tema serupa — untuk menjelajahi ketakutan terkait.
Kafein berlebih
Berapa peluang mengalami bahaya akibat terlalu banyak minum kopi atau kafein?
GLP-1: aspirasi saat anestesi
Jika Anda mengonsumsi obat GLP-1, apakah isi lambung yang tertinggal akan menyebabkan Anda mengalami aspirasi selama anestesi umum?
Produk impor tidak aman
Berapa kemungkinan terluka oleh produk konsumen impor yang tidak aman?
Obat palsu
Berapa peluang dirugikan atau meninggal karena obat palsu atau berkualitas rendah?
Pilih penantang
Between August 2019 and February 2020, the CDC tracked 2,807 hospitalizations and 68 deaths in the United States linked to e-cigarette or vaping product use — a cluster of severe lung injuries that came to be known as EVALI (e-cigarette or vaping product use–associated lung injury). In the Illinois–Wisconsin case series that first characterized the cluster, the median age of affected patients was 21, and about a quarter (26%) required intubation. By the time the CDC closed active surveillance in February 2020, 82% of confirmed cases involved THC-containing products, and vitamin E acetate — an oil-based thickening agent added to illicit THC vaping cartridges — was identified as the primary causative agent. Once the CDC and FDA issued warnings and states moved to remove adulterated products from circulation, the outbreak curve broke sharply.
The outbreak was genuine and serious, but it was causally specific in a way the subsequent fear has not always respected. EVALI was not a general risk of vaping; it was a risk of vaping from unregulated THC cartridges adulterated with a specific compound in the US supply chain at a specific moment. No comparable EVALI outbreak occurred in other countries, which did not have the same black-market THC vaping cartridge market. For US teens who vape regulated nicotine products — now the dominant form of teen vaping, at 7.8% of US high schoolers in 2024, down from 10.0% in 2023 — the specific EVALI risk profile from the outbreak era does not apply. The ongoing health risks of adolescent nicotine vaping are real but distinct: respiratory function effects, nicotine dependence, potential cardiovascular exposure, and the longer-term cancer question (covered in a separate entry, where the evidence supports a hazard but not yet a quantifiable lifetime probability) are documented concerns that fall outside the acute EVALI framework.
The roughest probability estimate for the outbreak period is approximately 1 in 1,070 across all US teenage and young-adult vapers, or higher still if the denominator is limited to those who used THC-containing products specifically. The current background EVALI rate for users of regulated nicotine products is an order of magnitude lower. The outbreak is the canonical example of a risk that was real, temporary, causally specific, and subsequently dissipated through intervention — yet the reputational effect on vaping broadly persists at a level uncalibrated to the current risk landscape.
Fakta terkait
Bahkan selama wabah EVALI 2019-2020, rawat inap berkisar sekitar 1 dari 1,070 pengguna vape remaja dan dewasa muda di AS, sebagian besar dipicu oleh produk THC ilegal. Sekitar 2,807 orang dirawat inap secara nasional. Cedera nyata, tetapi jauh lebih langka daripada yang disiratkan liputan wabah.
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
2/4 sumber diverifikasi secara independen kata demi kata terhadap sumber terkutip
-
[1] Centers for Disease Control and Prevention — Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products (EVALI) — Final Update Terverifikasi
Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products (EVALI) — Final Update- Statistik
2,807 hospitalized EVALI cases and 68 deaths reported to CDC by February 18, 2020; 82% involved THC products; vitamin E acetate identified as primary culprit- Kutipan
“"As of February 18, 2020, a total of 2,807 hospitalized EVALI cases or deaths have been reported to CDC from 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Among those with information on substances used, 82 percent reported using THC-containing products. Vitamin E acetate has been strongly linked to the EVALI outbreak. CDC, states, and the FDA recommend that people not use THC-containing e-cigarette or vaping products, particularly from informal sources like friends, family, or in-person or online dealers." ”
- Data sumber dari
- 2020-02-25
- Diakses
- 2026-05-04 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- CDC final EVALI update — source of the 2,807 numerator only. 2,807 hospitalizations / an internal ~3 million working-estimate denominator of US teen + young adult vapers during the outbreak window ≈ 0.00094 (roughly 1 in 1,070). The denominator is not from this source; see the 2019 NYTS (Cullen et al.) entry, which anchors current youth vapers at ~5.3 million (a larger figure → rarer true rate). Since ~82% of cases involved THC products, the rate for THC-product users specifically is higher. The post-vit-E-removal era (post-2020) has a substantially lower rate; the figure here reflects the outbreak-era population-average risk across all teen/young-adult vapers.
-
[2] JAMA — e-Cigarette Use Among Youth in the United States, 2019
e-Cigarette Use Among Youth in the United States, 2019- Statistik
In 2019 (outbreak year), an estimated 4.1 million US high school students (27.5%) and 1.2 million middle school students (10.5%) currently used e-cigarettes — ~5.3 million youth vapers- Kutipan
“"An estimated 27.5% (95% CI, 25.3%-29.7%) of high school students and 10.5% (95% CI, 9.4%-11.8%) of middle school students reported current e-cigarette use. ... With the assumption that the prevalence estimates from this survey are nationally representative and could be used to project to national population totals for US high school and middle school students, the data would suggest that in 2019, an estimated 4.1 million high school students and 1.2 million middle school students currently use e-cigarettes." ”
- Data sumber dari
- 2019-11-05
- Diakses
- 2026-07-14 · salinan arsip
- Perhitungan
- Cullen et al., JAMA 2019 (CDC-authored analysis of the 2019 National Youth Tobacco Survey, N=19,018). Establishes the outbreak-era youth vaping denominator: ~4.1 million high school + ~1.2 million middle school = ~5.3 million current youth e-cigarette users in 2019, the peak EVALI year. This is the citable anchor for the "millions of teen/young-adult vapers" denominator used in the headline. Note NYTS surveys only middle + high school students (all under 18); the EVALI case series had a median age of 21 (NEJM), so the true exposed population extends into young adults beyond this frame and is therefore ≥5.3 million. A larger true denominator makes the outbreak rate RARER than the displayed ~1 in 1,070 (which divides by an internal 3,000,000 working estimate) — the headline is thus, if anything, on the more-alarming side, not conservative.
-
[3] New England Journal of Medicine — Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report Terverifikasi
Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report- Statistik
Case series of 98 EVALI patients: median age 21, 89% used THC products, 95% hospitalized; 26% required intubation and mechanical ventilation- Kutipan
“"There were 98 case patients, 79% of whom were male; the median age of the patients was 21 years. A total of 95% of the patients were hospitalized, 26% underwent intubation and mechanical ventilation, and two deaths were reported. A total of 89% of the patients reported having used tetrahydrocannabinol products in e-cigarette devices, although a wide variety of products and devices was reported." ”
- Data sumber dari
- 2020-03-05
- Diakses
- 2026-05-04 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- Layden et al. NEJM 2020 — final report from the two states that first identified the EVALI cluster. Establishes clinical severity (median age 21, 95% hospitalized, 26% intubated) and THC product involvement (89%). Confirms CDC's national pattern. Used to characterize the severity of the outcome (serious_harm) and the THC-product causation.
-
[4] CDC / Morbidity and Mortality Weekly Report — Tobacco Product Use Among US Middle and High School Students — National Youth Tobacco Survey, 2024
Tobacco Product Use Among US Middle and High School Students — National Youth Tobacco Survey, 2024See all 2 Likelier entries citing this source →
- Statistik
7.8% of US high school students currently used e-cigarettes in 2024 (down from 10.0% in 2023; ~1.21 million students); e-cigarettes remained the most commonly used tobacco product among youth- Kutipan
“"E-cigarettes were the most commonly used product (7.8%) among high school students. Among high school students, declines occurred in current use of any tobacco product (from 12.6% to 10.1%) and e-cigarettes (from 10.0% to 7.8%). Overall, current e-cigarette use decreased (from 1.56 million to 1.21 million) high school students from 2023 to 2024." ”
- Data sumber dari
- 2024-10-17
- Diakses
- 2026-05-04 · salinan arsip
- Perhitungan
- CDC NYTS 2024. Provides the current teen vaping prevalence denominator context (7.8% of high schoolers, ~1.21 million students). The decline from 10.0% (2023) to 7.8% (2024) — and the broader fall from the ~27% peak years earlier — confirms that the outbreak-era exposure scenario is no longer current. The current background EVALI rate among regulated nicotine vapers is substantially lower; the normalized rate reflects the outbreak-era THC-vaping scenario.